|
EYA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25530000230734E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.93559999642312E-08 |
| Normal-vs-Stage2 |
1.637800E-04 |
| Normal-vs-Stage3 |
2.581600E-04 |
| Normal-vs-Stage4 |
9.057800E-02 |
| Stage1-vs-Stage2 |
5.873600E-01 |
| Stage1-vs-Stage3 |
9.051200E-01 |
| Stage1-vs-Stage4 |
9.446400E-01 |
| Stage2-vs-Stage3 |
6.399600E-01 |
| Stage2-vs-Stage4 |
8.844000E-01 |
| Stage3-vs-Stage4 |
8.925600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.51729999862272E-08 |
| Normal-vs-AfricanAmerican |
2.16500040117751E-10 |
| Normal-vs-Asian |
3.81740000000574E-05 |
| Caucasian-vs-AfricanAmerican |
9.205700E-02 |
| Caucasian-vs-Asian |
9.736700E-03 |
| AfricanAmerican-vs-Asian |
2.594200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.29990471112274E-11 |
| Normal-vs-Female |
3.144100E-03 |
| Male-vs-Female |
4.097100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.2518000000481E-06 |
| Normal-vs-Extreme_Weight |
1.52489998406224E-09 |
| Normal-vs-Obese |
1.50000999999955E-05 |
| Normal-vs-Extreme_Obese |
5.624800E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.539400E-01 |
| Normal_Weight-vs-Obese |
4.431600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.832000E-01 |
| Extreme_Weight-vs-Obese |
6.499600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.110800E-01 |
| Obese-vs-Extreme_Obese |
7.468400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.772100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.04759999997039E-06 |
| Normal-vs-Age(61-80Yrs) |
1.7564000254211E-09 |
| Normal-vs-Age(81-100Yrs) |
3.3955000000585E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.375000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.527200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.946150E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.581570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.009600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.534000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.17189999926381E-08 |
| Normal-VS-Type2 PRCC |
1.88140000245696E-08 |
| Normal-VS-KIRP CIMP |
8.156200E-01 |
| Normal-VS-Unclassified PRCC |
2.264000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.693200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.423600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.457800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.179000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.295900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.472600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.14029896636225E-11 |
| Normal-vs-N1 |
6.297200E-03 |
| Normal-vs-N2 |
9.062400E-01 |
| N0-vs-N1 |
2.782000E-01 |
| N0-vs-N2 |
5.060000E-01 |
| N1-vs-N2 |
6.452200E-01 |
|
|
